NO934501D0 - Carboxylic acid derivatives, drugs containing these compounds, and processes for their preparation - Google Patents
Carboxylic acid derivatives, drugs containing these compounds, and processes for their preparationInfo
- Publication number
- NO934501D0 NO934501D0 NO934501D NO934501D NO934501D0 NO 934501 D0 NO934501 D0 NO 934501D0 NO 934501 D NO934501 D NO 934501D NO 934501 D NO934501 D NO 934501D NO 934501 D0 NO934501 D0 NO 934501D0
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- processes
- preparation
- carboxylic acid
- acid derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/38—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4241632A DE4241632A1 (en) | 1992-12-10 | 1992-12-10 | New (aza)aromatic or alicyclic carboxylic acid cpds. - used e.g. for treating thrombosis, inflammation, osteoporosis, cardiac infarct or tumour metastasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO934501D0 true NO934501D0 (en) | 1993-12-09 |
Family
ID=6474905
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO934501A NO934501L (en) | 1992-12-10 | 1993-12-09 | Carboxylic acid derivatives, drugs containing these compounds, and process for their preparation |
| NO934501D NO934501D0 (en) | 1992-12-10 | 1993-12-09 | Carboxylic acid derivatives, drugs containing these compounds, and processes for their preparation |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO934501A NO934501L (en) | 1992-12-10 | 1993-12-09 | Carboxylic acid derivatives, drugs containing these compounds, and process for their preparation |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0604800A1 (en) |
| JP (1) | JPH06239817A (en) |
| KR (1) | KR940014330A (en) |
| CN (1) | CN1094035A (en) |
| AU (1) | AU5230693A (en) |
| CA (1) | CA2111035A1 (en) |
| CZ (1) | CZ270593A3 (en) |
| DE (1) | DE4241632A1 (en) |
| FI (1) | FI935513A (en) |
| HU (1) | HU9303521D0 (en) |
| IL (1) | IL107956A0 (en) |
| MX (1) | MX9307781A (en) |
| NO (2) | NO934501L (en) |
| NZ (1) | NZ250391A (en) |
| PL (1) | PL301396A1 (en) |
| SK (1) | SK128193A3 (en) |
| ZA (1) | ZA939230B (en) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4326344A1 (en) * | 1993-08-05 | 1995-02-09 | Thomae Gmbh Dr K | Carbonamides, pharmaceutical compositions containing these compounds and process for their preparation |
| US5814636A (en) * | 1994-07-15 | 1998-09-29 | Meiji Seika Kabushiki Kaisha | Compounds with platelet aggregation inhibitor activity |
| GB9514160D0 (en) * | 1994-07-25 | 1995-09-13 | Zeneca Ltd | Aromatic compounds |
| GB9417532D0 (en) * | 1994-08-31 | 1994-10-19 | Zeneca Ltd | Aromatic compounds |
| GB9420557D0 (en) * | 1994-10-12 | 1994-11-30 | Zeneca Ltd | Aromatic compounds |
| US6069143A (en) * | 1994-12-20 | 2000-05-30 | Smithkline Beecham Corporation | Fibrinogen receptor antagonists |
| TW502026B (en) * | 1995-06-20 | 2002-09-11 | Zeneca Ltd | Aromatic compounds useful as antagonists of e-type prostaglandins, processes for the preparation thereof, pharmaceutical compositions comprising the compounds, and intermediates |
| TW434240B (en) * | 1995-06-20 | 2001-05-16 | Zeneca Ltd | Aromatic compounds, preparation thereof and pharmaceutical composition comprising same |
| DE69635254T2 (en) * | 1995-07-07 | 2006-07-13 | Astrazeneca Ab | Ortho-substituted aromatic compounds containing three (het) aryl rings, their preparation and their use as prostaglandin E2 (PGE2) antagonists |
| DE19614204A1 (en) * | 1996-04-10 | 1997-10-16 | Thomae Gmbh Dr K | Carboxylic acid derivatives, medicaments containing these compounds, their use and processes for their preparation |
| US5854245A (en) * | 1996-06-28 | 1998-12-29 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| AU6320998A (en) * | 1997-02-21 | 1998-09-09 | Bristol-Myers Squibb Company | Benzoic acid derivatives and related compounds as antiarrhythmic agents |
| GEP20063741B (en) | 2001-02-23 | 2006-02-10 | Merck & Co Inc | Nonaryl-Heterocyclic NMDA/NR2B Antagonists |
| RS20050532A (en) | 2003-01-14 | 2007-12-31 | Arena Pharmaceuticals Inc., | 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| PL378295A1 (en) * | 2003-02-24 | 2006-03-20 | Arena Pharmaceuticals, Inc. | Substituted aryl and heteroaryl derivatives as modulators of glucose metabolism and the prophylaxis and treatment of disorders thereof |
| US7592360B2 (en) | 2003-06-04 | 2009-09-22 | Merck & Co., Inc. | 3-fluoro-piperidines as NMDA/NR2B antagonists |
| AR045047A1 (en) | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | ARILO AND HETEROARILO DERIVATIVES TRISUSTITUIDOS AS MODULATORS OF METABOLISM AND PROFILAXIS AND TREATMENT OF DISORDERS RELATED TO THEMSELVES |
| EA011010B1 (en) | 2004-02-27 | 2008-12-30 | Эмджен, Инк. | Compounds modulating of gpr40 receptor, pharmaceutical composition, method for treating diseases responsive to the modulation of gpr40 receptor (embodiments), method for modulating gpr40 function (embodiments) and method for modulating circulating insulin concentration |
| JP4875978B2 (en) * | 2004-03-15 | 2012-02-15 | 武田薬品工業株式会社 | Aminophenylpropanoic acid derivatives |
| DOP2006000010A (en) | 2005-01-10 | 2006-07-31 | Arena Pharm Inc | PROCEDURE TO PREPARE AROMATIC ETERES |
| MY148521A (en) | 2005-01-10 | 2013-04-30 | Arena Pharm Inc | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| US7465804B2 (en) | 2005-05-20 | 2008-12-16 | Amgen Inc. | Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders |
| AU2006291234A1 (en) | 2005-09-14 | 2007-03-22 | Amgen Inc. | Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
| WO2008030520A1 (en) | 2006-09-07 | 2008-03-13 | Amgen Inc. | Heterocyclic gpr40 modulators |
| WO2008030618A1 (en) | 2006-09-07 | 2008-03-13 | Amgen Inc. | Benzo-fused compounds for use in treating metabolic disorders |
| JP2010524932A (en) | 2007-04-16 | 2010-07-22 | アムジエン・インコーポレーテツド | Substituted biphenylphenoxy-, thiophenyl- and aminophenylpropanoic acid GPR40 modulators |
| EP2205548A1 (en) | 2007-10-10 | 2010-07-14 | Amgen, Inc | Substituted biphenyl gpr40 modulators |
| WO2009111056A1 (en) | 2008-03-06 | 2009-09-11 | Amgen Inc. | Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders |
| ES2450567T3 (en) | 2008-10-15 | 2014-03-25 | Amgen, Inc | GPR40 spirocyclic modulators |
| SG188548A1 (en) | 2010-09-22 | 2013-04-30 | Arena Pharm Inc | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| TW201329025A (en) | 2011-11-01 | 2013-07-16 | Astex Therapeutics Ltd | Pharmaceutical compounds |
| NZ734220A (en) | 2015-01-06 | 2022-01-28 | Arena Pharm Inc | Methods of treating conditions related to the s1p1 receptor |
| CN108349891B (en) | 2015-06-22 | 2022-04-05 | 艾尼纳制药公司 | Crystalline L-arginine salt of a compound for use in S1P1 receptor-related disorders |
| WO2018151873A1 (en) | 2017-02-16 | 2018-08-23 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of primary biliary cholangitis |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4402975A (en) * | 1980-07-21 | 1983-09-06 | Teijin Limited | Aminocarboxylic acids, amino alcohols, or the derivatives thereof, processes for production thereof, and pharmaceutical uses thereof |
| DE3718638A1 (en) * | 1987-06-04 | 1988-12-22 | Thomae Gmbh Dr K | NEW PHENYLETHANOLAMINE, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
| US5039805A (en) * | 1988-12-08 | 1991-08-13 | Hoffmann-La Roche Inc. | Novel benzoic and phenylacetic acid derivatives |
| NZ239876A (en) * | 1990-09-27 | 1993-12-23 | Merck & Co Inc | Glycyl-b-alanine derivatives and pharmaceutical compositions thereof. |
| DE4035961A1 (en) * | 1990-11-02 | 1992-05-07 | Thomae Gmbh Dr K | CYCLIC IMINODERIVATES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
| DE4102024A1 (en) * | 1991-01-24 | 1992-07-30 | Thomae Gmbh Dr K | BIPHENYL DERIVATIVES, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND METHOD FOR THE PRODUCTION THEREOF |
| DE4127404A1 (en) * | 1991-08-19 | 1993-02-25 | Thomae Gmbh Dr K | CYCLIC IMINODERIVATES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
| DE4213931A1 (en) * | 1992-04-28 | 1993-11-04 | Thomae Gmbh Dr K | CYCLIC IMINODERIVATES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
| DE4213919A1 (en) * | 1992-04-28 | 1993-11-04 | Thomae Gmbh Dr K | CYCLIC IMINODERIVATES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS CONTAINING SUCH COMPOUNDS |
-
1992
- 1992-12-10 DE DE4241632A patent/DE4241632A1/en not_active Withdrawn
-
1993
- 1993-11-17 SK SK1281-93A patent/SK128193A3/en unknown
- 1993-12-08 NZ NZ250391A patent/NZ250391A/en unknown
- 1993-12-08 CA CA002111035A patent/CA2111035A1/en not_active Abandoned
- 1993-12-08 EP EP93119786A patent/EP0604800A1/en not_active Withdrawn
- 1993-12-09 MX MX9307781A patent/MX9307781A/en unknown
- 1993-12-09 HU HU9303521A patent/HU9303521D0/en unknown
- 1993-12-09 ZA ZA939230A patent/ZA939230B/en unknown
- 1993-12-09 IL IL10795693A patent/IL107956A0/en unknown
- 1993-12-09 KR KR1019930027010A patent/KR940014330A/en not_active Application Discontinuation
- 1993-12-09 JP JP5308419A patent/JPH06239817A/en active Pending
- 1993-12-09 FI FI935513A patent/FI935513A/en not_active Application Discontinuation
- 1993-12-09 NO NO934501A patent/NO934501L/en unknown
- 1993-12-09 NO NO934501D patent/NO934501D0/en unknown
- 1993-12-09 PL PL93301396A patent/PL301396A1/en unknown
- 1993-12-10 CZ CZ932705A patent/CZ270593A3/en unknown
- 1993-12-10 AU AU52306/93A patent/AU5230693A/en not_active Abandoned
- 1993-12-10 CN CN93120876A patent/CN1094035A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR940014330A (en) | 1994-07-18 |
| NZ250391A (en) | 1996-06-25 |
| ZA939230B (en) | 1995-06-09 |
| FI935513A0 (en) | 1993-12-09 |
| JPH06239817A (en) | 1994-08-30 |
| PL301396A1 (en) | 1994-07-25 |
| AU5230693A (en) | 1994-06-23 |
| SK128193A3 (en) | 1995-02-08 |
| CA2111035A1 (en) | 1994-06-11 |
| CZ270593A3 (en) | 1994-11-16 |
| IL107956A0 (en) | 1994-04-12 |
| NO934501L (en) | 1994-06-13 |
| FI935513A (en) | 1994-06-11 |
| DE4241632A1 (en) | 1994-06-16 |
| MX9307781A (en) | 1994-06-30 |
| HU9303521D0 (en) | 1994-04-28 |
| CN1094035A (en) | 1994-10-26 |
| EP0604800A1 (en) | 1994-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO934501D0 (en) | Carboxylic acid derivatives, drugs containing these compounds, and processes for their preparation | |
| NO933647D0 (en) | CARBOXYLIC ACID DERIVATIVES, PHARMACEUTICALS CONTAINING THESE AND PROCEDURES FOR THEIR PREPARATION | |
| NO933248D0 (en) | Cyclic urea derivatives, drugs containing these compounds, and processes for their preparation | |
| NO924027D0 (en) | Heterobia Age Derivatives, Drugs Containing These Compounds, and Procedures for Their Preparation | |
| NO930517D0 (en) | BENZIMIDAZOLYL DERIVATIVES, PHARMACEUTICALS CONTAINING THESE, AND PROCEDURES FOR THEIR PREPARATION | |
| NO932120D0 (en) | BIFENYL DERIVATIVES, PHARMACEUTICALS CONTAINING THESE, AND PROCEDURE FOR THEIR PREPARATION | |
| DK362787A (en) | BENZENSULPHONAMIDO-INDANYL COMPOUNDS, PHARMACEUTICALS CONTAINING THESE COMPOUNDS AND PROCEDURES FOR THEIR PREPARATION | |
| NO880443D0 (en) | N-HETERYCYCLIC-N- (4-PIPERIDYL) AMIDES AND PHARMACEUTICAL PREPARATIONS AND PROCEDURES FOR USING SUCH COMPOUNDS. | |
| DK498988D0 (en) | 3,7-DIAZABICYCLOOE3,3,1AANONANE COMPOUNDS, PROCEDURES FOR THEIR PRODUCTION AND HEART-EFFECTIVE MEDICINES CONTAINING THESE | |
| NO934196D0 (en) | N, N-disubstituted arylcycloalkylamines, their salts, drugs containing these compounds, their use and process for their preparation | |
| DK162491D0 (en) | Heterocyclic compounds, their preparation and pharmaceutical preparations containing the compounds | |
| DK241585A (en) | 8-CHLORO-QUINOLINCARBOXYLIC ACID DERIVATIVES, PROCEDURES FOR PREPARING IT AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS | |
| DK162221C (en) | CINNOL COMPOUNDS, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THE COMPOUNDS | |
| NO932636L (en) | Benzimidazoles, drugs containing these compounds, and methods for their preparation | |
| DK0838469T3 (en) | 10,13,15-Trioxatricyclo (9.2.1 9.6) -pentadecanone derivatives, process for their preparation, and drugs containing these compounds | |
| NO930796D0 (en) | GLYCOPEPTY DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING THESE | |
| DK102990A (en) | THIENO-TRIAZOLODIAZEPINE DERIVATIVES, PROCEDURES FOR THE PREPARATION OF SUCH COMPOUNDS, AND MEDICINES CONTAINING THESE | |
| DK712388A (en) | HETEROCYCLIC SUBSTITUTED OXO- OR THIOPHTHALAZINYL-ACETIC ACID COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE | |
| DK457787A (en) | SULPHONAMIDOETHYL COMPOUNDS, PHARMACEUTICALS CONTAINING THESE COMPOUNDS AND PROCEDURES FOR THEIR PREPARATION | |
| DE59402621D1 (en) | Fluorotrifluoromethylbenzoic acid derivatives | |
| NO933558D0 (en) | BENZIMIDAZOLES, PHARMACEUTICALS CONTAINING THESE COMPOUNDS, AND PROCEDURE FOR THEIR PREPARATION | |
| DK187989D0 (en) | SUBSTITUTED PROPANAMINES, PROCEDURES FOR THE PREPARATION OF THEM, AND PHARMACEUTICALS CONTAINING SUCH COMPOUNDS | |
| DK606488A (en) | PYRIDOXYL HYDRAZONE DERIVATIVES AND PHARMACEUTICAL COMPOUNDS CONTAINING THESE | |
| DK493988D0 (en) | 4-OXO-3-QUINOLINCARBOXYLIC ACIDS, PROCEDURES FOR PREPARING THEM AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS | |
| NO951350D0 (en) | Pharmaceutical preparations containing 3-substituted 2-oxindole-1-carboxamides |